PUBLISHER: TechNavio | PRODUCT CODE: 1774404
PUBLISHER: TechNavio | PRODUCT CODE: 1774404
The antibody market is forecasted to grow by USD 8,958 mn during 2024-2029, accelerating at a CAGR of 8.3% during the forecast period. The report on the antibody market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and innovation in antibody engineering, expanding therapeutic applications and addressing high unmet medical needs, and rising prevalence of chronic diseases and a favorable regulatory environment.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 8.2% |
CAGR | 8.3% |
Incremental Value | $8,958 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's antibody market is segmented as below:
By Type
By Therapeutic Area
By Application
By Geographical Landscape
This study identifies the ascendancy of next-generation antibody constructs as one of the prime reasons driving the antibody market growth during the next few years. Also, intensification of precision medicine and companion diagnostics and expansion into novel and high-impact therapeutic frontiers will lead to sizable demand in the market.
The report on the antibody market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibody market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Cell Signaling Technology Inc., Celltrion Co. Ltd., Creative Biolabs, Danaher Corp., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Johnson and Johnson Services Inc., Leinco Technologies Inc., Merck and Co. Inc., Novartis AG, Novus Biologicals, Pfizer Inc., Proteintech Group, Regeneron Pharmaceuticals Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the antibody market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: